NCT05413135Phase 2Completed

Study of ARO-APOC3 in Adults With Dyslipidemia

Study sponsor: Arrowhead Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2025-09-22Actual
Enrollment · participants418Actual
Source updated2026-05-12Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

18 Sep 2025

+ After

22 Sep 2025

Check registry source

· 3 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Sep 2025

+ After

18 Sep 2025

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source